We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
115 hedge funds and large institutions have $2.04B invested in Kymera Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,285% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $549K
186% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 22
58% more capital invested
Capital invested by funds: $1.29B → $2.04B (+$749M)
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
8.91% more ownership
Funds ownership: 58.95% → 67.86% (+8.9%)
5% more funds holding
Funds holding: 110 → 115 (+5)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
115
Holders Change
+5
Holders Change %
+4.55%
% of All Funds
2.01%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
21
Increased
63
Reduced
22
Closed
16
Calls
$13.1M
Puts
$549K
Net Calls
+$12.5M
Net Calls Change
+$5.12M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$95.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$80.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49.7M |
| 4 |
BlackRock
New York
|
+$34.3M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$32M |
